Apogee Therapeutics Inc [APGE] stock prices are down -0.86% to $76.09 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The APGE shares have gain 10.34% over the last week, with a monthly amount glided 38.36%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Apogee Therapeutics Inc [NASDAQ: APGE] stock has seen the most recent analyst activity on November 03, 2025, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $109. Previously, Mizuho started tracking the stock with Outperform rating on October 21, 2025, and set its price target to $105. On September 25, 2025, RBC Capital Mkts initiated with a Outperform rating and assigned a price target of $60 on the stock. BTIG Research reiterated its Buy rating and increased its price target to $115 on July 07, 2025. Citigroup initiated its recommendation with a Buy and recommended $95 as its price target on March 13, 2025. Canaccord Genuity started tracking with a Buy rating for this stock on November 25, 2024, and assigned it a price target of $89. In a note dated May 10, 2024, BofA Securities initiated an Buy rating and provided a target price of $80 on this stock.
The stock price of Apogee Therapeutics Inc [APGE] has been fluctuating between $26.20 and $77.08 over the past year. Currently, Wall Street analysts expect the stock to reach $84.5 within the next 12 months. Apogee Therapeutics Inc [NASDAQ: APGE] shares were valued at $76.09 at the most recent close of the market. An investor can expect a potential return of 11.05% based on the average APGE price forecast.
Analyzing the APGE fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.35 and Total Capital is -0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 72.27 points at the first support level, and at 68.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 78.18, and for the 2nd resistance point, it is at 80.26.
Ratios To Look Out For
It’s worth pointing out that Apogee Therapeutics Inc [NASDAQ:APGE]’s Current Ratio is 15.86. As well, the Quick Ratio is 15.86, while the Cash Ratio is 3.17.
Transactions by insiders
Recent insider trading involved Dambkowski Carl, Chief Medical Officer, that happened on Dec 04 ’25 when 10900.0 shares were sold. Chief Financial Officer, Henderson Jane completed a deal on Dec 04 ’25 to sell 1500.0 shares. Meanwhile, Chief Executive Officer HENDERSON MICHAEL THOMAS sold 40000.0 shares on Dec 04 ’25.
